Translation of "N vestibulocochlearis" to English language:
Examples (External sources, not reviewed)
| Therapeutisches HBV DNA HBeAg Sero ALT Virologischer Ansprechen PCR negativ konversion Normalisierung Durchbruch n N ( ) n N ( ) n N ( ) n N ( ) n N ( ) | Outcome for key efficacy end points at 104 weeks based on week 24 results Therapeutic PCR negative HBeAg ALT Virological response HBV DNA seroconversion normalisation breakthrough n N ( ) n N ( ) n N ( ) n N ( ) n N ( ) |
| n 53 n 110 n ( ) n ( ) | N 110 n ( ) |
| n 53 n 110 n ( ) n ( ) | MTX N 110 n ( ) |
| 1,3 Propandiaminium, 2 Hydroxy N, N,N, N',N',N' hexamethyl , Diiodid | 1,3 Propanediaminium, 2 hydroxy N,N,N,N',N',N' hexamethyl , diiodide |
| N,N,N',N' Tetramethyl 4,4' methylendianilin | N,N,N ,N tetramethyl 4,4 methylendianiline |
| N,N,N ,N Tetramethyl 4,4 methylendianilin | N,N,N ,N tetramethyl 4,4 methylendianiline |
| Yea n 1 n 2 n 3 n 4 n 5 21 r n | Yea n 1 n 2 n 3 n 4 n 5 21 r n |
| 1,3 Propandiaminium, 2 Hydroxy N, N' bis(octadecyl) N, N,N',N' tetramethyl , Chlorid | 1,3 propanediaminium, 2 hydroxy N,N' bis(octadecyl) N,N,N',N' tetramethyl , chloride |
| Derzeit sind folgende natürlichen Hybriden bekannt N. edwardsiana N. rajah N. fusca N. rajah N. macrovulgaris N. rajah N. stenophylla N. rajah N. tentaculata N. rajah N. alisaputrana Adam Wilcock (1992) N. burbidgeae N. rajah N. kinabaluensis S. Kurata, nom. | At present, the following natural hybrids are known N. burbidgeae N. rajah N. alisaputrana J.H.Adam Wilcock (1992) N. edwardsiana N. rajah N. fusca N. rajah N. lowii N. rajah N. macrovulgaris N. rajah N. rajah N. stenophylla N. rajah N. tentaculata N. rajah N. villosa N. kinabaluensis Sh.Kurata (1976) nom.nud. |
| 1,2 Ethandiamin, N,N,N',N' tetrakis(carboxymethyl) | 1,2 Ethanediamine, N,N,N',N' tetrakis(carboxymethyl) |
| n 166 n n n n n 193 n 196 n 196 n 46 Woche 162 162 164 164 Woche Woche Woche Woche Woche Woche | BIW Placebo BIW BIW Placebo QW |
| 1,3 Propandiaminium, 2 Hydroxy N, N' bis(9 octadecenyl) N, N,N',N' tetramethyl , Chlorid | 1,3 propanediaminium, 2 hydroxy N,N' bis(9 octadecenyl) N,N,N',N' tetramethyl , chloride |
| Atripla (N 203) n N ( ) | Atripla (N 203) n N ( ) |
| Therapie (N 97) n N ( ) | (N 97) n N ( ) |
| N, N Dimethyldocosylamin N oxid | N, N dimethyldocosylamine N oxide |
| N, N Dimethyldecylamin, N Oxid | N,N dimethyldecylamine N oxide |
| N,N Dimethyltetradecylamin N oxid | N,N dimethyltetradecylamine N oxide |
| N,N Dimethyloleyl N oxid | N,N dimethyloleyl N oxide |
| N,N Dimethyloctadecylamin N oxid | N,N dimethyloctadecylamine N oxide |
| Calciat(2 ), N,N' 1,2 Ethandiylbis N (carboxymethyl)glycinato (4 ) N,N',O,O',O(N) ,O(N') , Dinatrium | Calciate(2 ), N, N' 1,2 ethanediylbis N (carboxymethyl)glycinato (4 ) N, N',O, O',O(N) ,O(N') , disodium |
| 2 (N,N Diethylamino)ethylchloridhydrochlorid, 2 (N,N Diisopropylamino)ethylchloridhydrochlorid und 2 (N,N Dimethylamino)ethylchloridhydrochlorid | Carbonates peroxocarbonates (percarbonates) commercial ammonium carbonate containing ammonium carbamate |
| Quartäre Ammoniumverbindungen, N,N,N' Tris(hydroxyethyl) N,N' dimethyl N' Talg alkyltrimethylendi , Bis(methylsulfate) (Salze) | Quaternary ammonium compounds, N,N,N' tris(hydroxyethyl) N,N' dimethyl N' tallow alkyltrimethylenedi , bis(Me sulfates) (salts) |
| N, N,N',N' Tetramethylethylendiaminbis(2 chlorethyl)ether Copolymer | N, N,N',N' Tetramethylethylenediamine bis(2 chloroethyl) ether copolymer |
| n N | n N |
| N n ( ) | N n ( ) |
| n N | n N |
| n N ( ) | n N ( ) n N ( ) |
| n ( ) n ( ) | MTX N 110 n ( ) |
| n ( ) N | n ( ) N |
| n N ( ) | n N ( ) |
| 1,3 Propandiaminium, 2 Hydroxy N, N' bis (1 oxoisooctadecyl)amino propyl N,N,N',N' tetramethyl , Chlorid | 1,3 propanediaminium, 2 hydroxy N,N' bis (1 oxoisooctadecyl)amino propyl N,N,N',N' tetramethyl , chloride |
| (n 661) (n 334) (n 661) | 90 mg bid (N 661) |
| Collagene, Hydrolysate, N,N,N Trimethylbenzolmethanaminiumsalze | Collagens, hydrolyzates, N,N,N trimethylbenzenemethanaminium salts |
| N,N' Ethylen Bis N acetylacetamid | N,N' ethylenebis N acetylacetamide |
| Ansprechen SVR (n N) Woche 12 99 CI (n N) | Response SVR (n N) Week 12 99 CI (n N) |
| Ansprechen SVR (n N) Woche 12 99 CI (n N) | Response SVR (n N) Week 12 99 CI (n N) |
| Propandiamid, N,N' bis(2 hydroxyethyl) N, N' bis(hexadecyl) | Propanediamide, N,N' bis(2 hydroxyethyl) N,N' bis(hexadecyl) |
| 1,3 Propandiamin, N,N Dimethyl , N' Nerzöl Acylderivate, N Oxide | 1,3 propanediamine, N,N dimethyl , N' mink oil acyl derivs., N oxides |
| Amine, N (C14 C16 Alkyl) N,N dimethyl , N Oxide | Amines, N (C14 C16 alkyl) N,N dimethyl , N oxides |
| Oxiranmethanaminium, N N,N Dimethyl N 9 octadecenyl , Chlorid (Z) | Oxiranemethanaminium, N,N dimethyl N 9 octadecenyl , chloride (Z) |
| Ethanaminium, N (Talg Alkyl) N,N dimethyl 2 oxo 2 amino , N,N' Methylenbis | Ethanaminium, N (tallow alkyl) N,N dimethyl 2 oxo 2 amino , N,N' methylenebis |
| Benzolmethanaminium, N,N Dimethyl N 3 aminopropyl , N Nerzöl Acylderivate, Chloride | Benzenemethanaminium, N,N dimethyl N 3 aminopropyl , N mink oil acyl derivs., chlorides |
| Benzolmethanaminium, N (3 Aminopropyl) N,N dimethyl , N Rapsöl Acylderivate, Chloride | Benzenemethanaminium, N (3 aminopropyl) N, N dimethyl , N rape oil acyl derivs., chlorides |
| 1 Hexadecanaminium, N,N,N Trimethyl , Bromid | 1 Hexadecanaminium, N,N,N trimethyl , bromide |
| 1 Hexadecanaminium, N,N,N Trimethyl , Chlorid | 1 Hexadecanaminium, N,N,N trimethyl , chloride |
